The Research of French PaRole OncO : A Peer Supported Program for Cancer Patients

NCT06817655 | Not Yet Recruiting

• 1 other identifier: 69HCL23_1301
• Study Type: interventional
• Target: 720
• Locations: 1 country
• Sites: 2

Brief Summary

Peer support is a valuable mode of accompaniment between individuals who are facing or have faced similar challenging life experiences. In this context, a patient advisor (PA) shares their experiential knowledge, derived from living with a disease, to offer emotional, experiential, and informational support to other patients. This PA intervention represents an innovative form of support for oncology patients, potentially addressing their needs more comprehensively throughout the care pathway by integrating psychosocial dimensions into the support approach. The present pilot study aims to investigate the implementation and effectiveness of the peer-to-peer support program "PaRole OncO France" in the oncology setting. The study will focus on:

1. 1.Evaluating clinical and psychosocial parameters
2. 2.Utilizing an in-depth multiple case study approach This research seeks to provide insights into how peer support can enhance the overall care experience for oncology patients, potentially leading to improved patient outcomes and a more holistic approach to cancer care.

Conditions

Cancer

Keywords

Peer support; Cancer; participatory research; Patient advisor

Outcome Measures

Primary Outcomes (1)

• Feasibility of implementation of the Peer Support Program in Oncology

  Acceptability of PH intervention by patients, professionals, and PAs Number of PHs integrated per unit Maintenance of PH activity during the study period in each unit Primary outcome measure is multidimensional by design, as the evaluation of a peer support program requires simultaneous analysis of complementary aspects (acceptability, feasibility, fidelity). These elements are inherently interconnected within our methodological framework.

  30 months

Secondary Outcomes (12)

• Evolution of stress levels

  Baseline

• Evolution of stress levels

  6 months

• Evolution of quality of life

  Baseline

• Evolution of quality of life

  1 month, 6 month

• Evolution of patient-perceived care experience

  Baseline

Study Arms (1)

Supportive care (PaRole OncO France program)

EXPERIMENTAL

Patients participate in the PaRole OncO France program for which they are matched with a patient advisor and followed throughout treatment in person and/or phone.

Behavioral: PaRole OncO France : Individual peer support

Interventions

PaRole OncO France : Individual peer support BEHAVIORAL

Following the development of the peer support program "PaRole OncO France", we are now proceeding with its implementation and evaluation through a pilot study. This study aims to derive both implementation-related and clinically relevant results. Prior to their assignment, all peer helpers undergo a comprehensive training course to ensure they are well-equipped for their role. Patients receive individual peer support during their treatment visits, providing real-time assistance and support within the clinical setting. The study incorporates three key measurement time points: 1. Baseline measurement (before the intervention) 2. After the intervention 3. Follow-up measurement (1months after the first intervention) 4. Follow-up measurement (6 months after the first intervention) At each time points, participants will complete a set of standardized questionnaires. These instruments are designed to capture relevant outcomes and experiences related to the peer support intervention.

Supportive care (PaRole OncO France program)

Eligibility Criteria

• Age: 15 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• Patient participants :
• Patients with newly diagnosed or recurrent cancer (urological, digestive, mammary, pulmonary, ORL, peritoneal carcinosis, melanoma, oncohaematology)
• French-speaking patients
• Patients adivsors :
• Patient advisors will be past cancer patients not currently undergoing treatment for their cancer, and considered without evidence of disease
• French-speaking patients

You may not qualify if:

• Patients participants :
• Not followed in one of the participating units
• Persons deprived of their liberty by judicial or administrative decision
• Persons not affiliated to a social security scheme or beneficiaries of a similar scheme
• Patient advisors :
• Recurrence of the disease
• Currently undergoing treatment for active cancer

Sponsors & Collaborators

• Hospices Civils de Lyon: lead

Study Sites (2)

Hospices Civils de Lyon

Lyon, 69495, France

Location

Hospices Civils de Lyon

Lyon, 69495, France

Location

MeSH Terms

Conditions

Neoplasms

Central Study Contacts

Juile HASEBAERT, PhD

CONTACT

4.72.11.51.65; julie.haesebaert01@chu-lyon1.fr

Anne TERMOZ

CONTACT

04 27 85 63 00; anne.termoz@chu-lyon.fr

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Model Details: The intervention consists of patient accompaniment by patient advisors. At least one patient advisor is recruited in each service participating in the study. Patients will be paired with patient advisor and can benefit from accompaniment during their hospital stays or remotely (by phone). The patient advisor will, in turn, be supported by the healthcare professionals' team as well as through a community of practice.

Study Record Dates

• First Submitted: January 29, 2025
• First Posted: February 10, 2025
• Study Start: March 15, 2025
• Primary Completion (Estimated): June 15, 2027
• Study Completion (Estimated): June 15, 2027
• Last Updated: February 10, 2025

Record last verified: 2025-01

Data Sharing

• IPD Sharing: Will not share

Locations

FR (2)